glutathione reduction pathway antioxidant system. a Schematics for the of Glutathione: Overview of its protective

While industrialization has brought many great innovations for a growing population, it has also introduced harmful elements that we must account for

NAFLD appears to be more frequent in industrialized countries, its global prevalence is about 25% and varies across different geographical areas, being higher in Middle East and South America and lower in Africa (33)

GLP-2 (1-33) is not approved for personal or therapeutic use

Opioid analgesics are generally avoided in liver disease due to increased sensitivity, prolonged effects, and risk of encephalopathy in advanced liver disease, though they may occasionally be used under specialist supervision with careful dose adjustment

Mechanistically, we attributed the observed phenotype to impaired LXR alpha, PPAR gamma, and glucocorticoid receptor (GR) signalling